Evidence and Guidance Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management
Description GHK-Cu serum a concentrated 1% copper peptide topical formulation for skin research applications
Removes dead skin cells and improves skin texture Reduces pigmentation and dark spots Brightens and revitalizes the complexion Customizable for different skin concerns Also Read: Chemical Peel vs Laser Treatment: Which One Works Better for Acne Marks
Fine-tuning doses to balance efficacy against adverse effects optimizes long-term outcomes
David Garcia takes a personalized, clinical approach to weight loss, targeting hormonal, metabolic, and lifestyle factors that often go overlooked
Nomoto H, Oba-Yamamoto C, Takahashi Y, Takeuchi J, Nagai S, Yokoyama H, et al